Eton Pharmaceuticals

Join Us This Week at ACMG 2025 in LA & CLDF Liver Connect in San Antonio! We’re gearing up for an exciting week at two major conferences, and we’d like to connect with you! 📍 ACMG 2025 – Los Angeles, CA 🗓 March 19-21, 2025 | 📌 Booth #828 | 📍 LA Convention Center Join us at the American College of Medical Genetics and Genomics (ACMG) 2025 to explore how we’re advancing patient care in metabolic disorders. Stop by booth #828 to learn more about our commitment to genetic and metabolic health. Let’s make the most of ACMG 2025—see you there! 📍 CLDF Liver Connect 2025 – San Antonio, TX 🗓 March 20-22, 2025 | 📌 Booth #10 | 📍 La Cantera Resort & Spa We’re also excited to attend the Chronic Liver Disease Foundation (CLDF) 5th Annual Liver Connect Conference! Visit us at booth #10 to discuss how we can support your patients and advance liver disease management. Don't miss this opportunity to engage with our team—we look forward to seeing you at ACMG and Liver Connect 2025! #ACMG2025 #LiverConnect2025 #RareDisease #PatientCare #EtonPharmaceuticals

We are thrilled to announce positive clinical study results from our product candidate ET-600, marking another significant milestone in our mission to bring innovative therapies to patients with rare diseases.   At Eton, we are dedicated to developing meaningful solutions that improve lives. These results bring us closer to providing a new treatment option for those who need it most.   🔗 Read the full press release here: https://lnkd.in/gKXNncXE.   Stay tuned for more updates as we continue expanding our portfolio and driving innovation in rare disease care. Together, we’re shaping a brighter future for patients everywhere.   #PatientFirst #RareDisease #EtonPharmaceuticals #Innovation #PressRelease

We are proud to announce the official launch of Galzin® (zinc acetate) capsules. This addition to our portfolio reflects our commitment to expanding access to critical treatments for patients with rare and underserved conditions. We remain dedicated to delivering high-quality therapies and advancing patient care through continued innovation and collaboration. Read the full press release: https://lnkd.in/gzAfDVaf. This content is intended for informational purposes only. For full prescribing information and more information about the launch of Galzin visit: www.galzin.com. #PatientFirst #RareDisease #Galzin #EtonPharmaceuticals #LaunchAnnouncement #PressRelease

While today is Rare Disease Day, our work continues every day to ensure that rare disease patients receive the care, support, and hope they deserve. Together, we have the power to drive meaningful change. At Eton Pharmaceuticals, we’re driven by a mission to provide treatment for those in greatest need and improve the lives of patients with rare diseases. Every breakthrough matters for those living with rare diseases. That’s why we are dedicated to expanding access to life-changing therapies and supporting patients at every stage. This year, let’s unite for breakthroughs, compassion, and hope. All together, helping all patients. Discover our mission: etonpharma.com/mission/ #RareDiseaseDay #RareDisease #TogetherForRare #PatientSupport #EtonPharmaceuticals #EtonCares

We’re #hiring! Eton Pharmaceuticals is seeking a Rare Disease Specialist to cover our Seattle territory. Apply today or share with your network!

We’re #hiring! Eton Pharmaceuticals is looking to add a Sales Analyst to our team. Apply today or share with your network!

February 28th is Rare Disease Day, a time to recognize the strength of individuals and families navigating these challenges. With over 300 million people worldwide affected by rare diseases, access to care, treatments, and support remains a critical challenge. By working together with patients, advocates, researchers, and healthcare providers, we can help bring meaningful change to those who need it most. Join the mission to help create change for people living with rare diseases by visiting www.rarediseaseday.org. #RareDiseaseDay #RareDisease #TogetherForRare #PatientSupport #EtonCares

At Eton Pharmaceuticals, innovation starts at the top. Our CEO, Sean Brynjelsen, is a visionary leader passionate about developing life-changing therapies.   Sean’s leadership is defined by his commitment to innovation, collaboration, and execution. Under his guidance, Eton continues to grow, bringing forward therapies that improve patient outcomes in rare diseases.   We are proud to have a leader who drives business success and inspires a mission-driven culture at Eton. #Leadership #CEOspotlight #EtonPharmaceuticals #Innovation #RareDisease #PharmaLeadership

Our recent National Sales Meeting was nothing short of inspiring! Together, we celebrated successes, sharpened our strategies, and embraced the theme of going ABOVE AND BEYOND in everything we do. This incredible team continues to set the bar high, striving to make a lasting impact for the patients and communities we serve. Here’s to collaboration, innovation, and a future full of possibilities. We’re ready to soar to new heights together! #AboveAndBeyond #EtonFamily #NationalSalesMeeting #Teamwork #Innovation #MakingADifference #EtonPharmaceuticals #RareDisease

Today, we honor the legacy of Dr. Martin Luther King Jr., whose vision for equality and justice inspires our commitment to health equity. In the healthcare industry, we strive to ensure that every individual has access to quality care. Let’s continue to work together to create a healthier and more inclusive future for all. #MLKDay #HealthcareForAll #EtonPharmaceuticals #RareDisease